Another cause for concern: flu season is underway in the U.S., and as seasonal influenza virus goes around, “humans, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE ...

Moreover, there is an unnecessary use of antivirals like Oseltamivir guidance," said Dr. Praveen Kumar Kulkarni, senior ...

The first week was the worst. “It was very, very, very deadly because the people had an advanced stage of disease, and the ...

There is reason to be optimistic about the future of dengue antivirals, and funding of dengue research in general. The 2010 G-FINDER report revealed over US$165 million in total global funding to ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

Most of the antiviral agents that have been approved, and are currently used in the treatment of virus infections, are targeted at HIV, HBV, herpes simplex virus (HSV), varicella-zoster virus (VZV ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

According to new research from the Cleveland Clinic published in The Lancet Infectious Diseases, updated COVID-19 vaccines—the monovalent (single-strain) XBB.1.5 shots—reduced the risk of severe COVID ...

With a test currently under FDA review, Inflammatix commences a 600 patient-strong clinical trial in emergency departments.

At Delhi's RML Hospital, home to India's 1st pollution OPD, doctors estimate that number of patients coming in weekly has ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.